Check-Cap Ltd Dossier - Source-backed chat

Check-Cap Ltd

MBAINASDAQ

SectorHealth Care

IndustryHealth Care Equipment

Beta (adjusted)0.83

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $3.16Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $48.3M

Enterprise Value $48.3M

Shares Outstanding 15.3M diluted

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Check-Cap Ltd. (NASDAQ: MBAI) is in the final stages of executing a transformative reverse merger with MBody AI Corp., an enterprise-grade embodied AI and robotics platform. Following shareholder approval in November 2025 and a ticker change from 'CHEK' to 'MBAI' in December 2025, the company is transitioning from a defunct medical diagnostics developer into a pure-play physical AI provider. Standalone Check-Cap operations generated a net income of $4.1 million in 2025 (primarily driven by a $6.5 million non-operating debt extinguishment gain) against an operating loss of $2.4 million. Meanwhile, merger target MBody AI reported profitable 2025 operations with $2.4 million in net revenue and $507,851 in net income. While the commercial momentum of MBody AI's platform is promising, the stock remains a 'Hold' until the merger officially closes and the combined entity demonstrates sustainable post-merger scaling and capital compliance.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.5015%

The merger faces unexpected regulatory delays or fails to meet Nasdaq's strict capital requirements for initial listing, leading to transaction termination or delisting. The company is forced to liquidate its remaining cash or seek alternative distressed transactions, destroying shareholder value.

Base CaseCentral scenario

$1.8070%

The merger with MBody AI closes successfully in mid-2026. The combined entity leverages its newly registered $30 million ARC Group equity line of credit to fund the commercial rollout of its MBody AI Orchestrator platform across Fortune 500 hospitality and commercial real estate clients, driving steady subscription-based revenue growth.

Bull CaseUpside scenario

$3.0025%

The merger closes successfully and MBody AI accelerates its commercial expansion, securing multiple enterprise-grade contracts across Fortune 500 hospitality and logistics clients. The combined entity achieves rapid subscription-based revenue growth, successfully scales its multi-robot fleet operating system, and maintains compliance with Nasdaq listing standards without significant dilutive equity raises.

Scenarios reflect our research view at the research date.

Key Investment Merits

Transition to a high-growth sector (embodied AI and enterprise robotics) with a hardware-agnostic platform.
Target company MBody AI is already profitable, reporting $507,851 in net income on $2.4 million in revenue for 2025.
Access to up to $30 million in discretionary growth capital via the ARC Group equity line of credit upon merger completion.

Key Investment Risks

Transaction completion risk; the merger remains subject to final Nasdaq listing approvals and capital requirements.
Severe dilution risk from the potential issuance of shares under the registered $30 million equity facility.
Historical going concern doubts and high dependence on successful post-merger integration and commercial scaling.

Thesis Invalidation Triggers

Termination of the Merger Agreement with MBody AI Corp.
Delisting notification from Nasdaq due to failure to meet minimum stockholders' equity or listing standards.
Failure to secure the necessary capital to fund combined operations, leading to insolvency.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.